Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trialPeter B. Gilbert, Bhavesh Borate, Lars W. P. van der Laan et al.|Science|2022Cited by 1.2k
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M. El Sahly, Jacqueline M. Miller, Lindsey R. Baden et al.|New England Journal of Medicine|2021Cited by 661
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy TrialPeter B. Gilbert, Richard A. Koup, David C. Montefiori et al.|medRxiv|2021Cited by 138
Safety and Immunogenicity of XBB.1.5-Containing mRNA VaccinesSpyros Chalkias, Rituparna Das, Nichole McGhee et al.|medRxiv|2023Cited by 79
Phase 3 Trial of mRNA-1273 during the Delta-Variant SurgeLindsey R. Baden, Jacqueline M. Miller, Hana M. El Sahly et al.|New England Journal of Medicine|2021Cited by 63